Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
<i>Background</i>: We sought to compare patterns of response to immune checkpoint inhibitors (ICI) with respect to clinical and genomic features in a retrospective cohort of patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). <i>Methods</i>...
Main Authors: | Panagiota Economopoulou, Maria Anastasiou, George Papaxoinis, Nikolaos Spathas, Aris Spathis, Nikolaos Oikonomopoulos, Ioannis Kotsantis, Onoufrios Tsavaris, Maria Gkotzamanidou, Niki Gavrielatou, Elena Vagia, Efthymios Kyrodimos, Eleni Gagari, Evangelos Giotakis, Alexander Delides, Amanda Psyrri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/2/286 |
Similar Items
-
Hyperprogression after immunotherapy in patients with malignant tumors of digestive system
by: Zhi Ji, et al.
Published: (2019-07-01) -
Clinical Benefit of Pazopanib in a Patient with Metastatic Chondrosarcoma: A Case Report and Review of the Literature
by: Onoufrios Tsavaris, et al.
Published: (2018-03-01) -
Editorial: Immunology and Immunotherapy of Head and Neck Cancer
by: Niki Gavrielatou, et al.
Published: (2021-12-01) -
Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
by: Panagiota Economopoulou, et al.
Published: (2019-08-01) -
Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma
by: Amanda Psyrri, et al.
Published: (2020-05-01)